2025 ESMO Highlights: Transformative Trends in Oncology
Over 3,000 abstracts were presented at ESMO 2025, with 790 identified as relevant to Beacon Oncology. Of these, more than 95% focused on clinical trials.
Key Highlights Include:
- An overview of the clinical trial landscape from ESMO 2025, covering key drugs, targets, and indications
- Insights on the continued dominance of checkpoint inhibitors and ADCs across oncology
- Key updates redefining first-line treatment strategies in lung and breast cancer
You May Also Be Interested In…
Learn More About Oncology
What is Beacon Oncology?
- The Most Comprehensive Way to Search the Oncology Drug Development Landscape: Unique search ontologies based on Oncology drug and trial characteristics
- Market Leading Approach to Oncology Preclinical & Clinical Data Curation: Manual curation of key Oncology research and development data points by Oncology research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Oncology company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
